| RS1489129465 |
FGFR1
|
Health Risk |
Pathogenic |
Hypogonadotropic hypogonadism 2 with or without anosmia, Hypogonadotropic hypogonadism 2 with or without anosmia |
| RS1489132337 |
KCNQ1
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Long QT syndrome |
| RS148913636 |
KCNQ4
|
Health Risk |
Conflicting classifications of pathogenicity |
KCNQ4-related disorder, KCNQ4-related disorder |
| RS148913728 |
TGM5
|
Health Risk |
Conflicting classifications of pathogenicity |
Acral peeling skin syndrome, TGM5-related disorder |
| RS148913798 |
PC
|
Health Risk |
Conflicting classifications of pathogenicity |
Pyruvate carboxylase deficiency, Inborn genetic diseases |
| RS1489140479 |
POLD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Colorectal cancer, susceptibility to |
| RS148914171 |
PEX5
|
Health Risk |
Conflicting classifications of pathogenicity |
Peroxisome biogenesis disorder 2B, Peroxisome biogenesis disorder 2B |
| RS148914290 |
SFTPB
|
Health Risk |
Conflicting classifications of pathogenicity |
Surfactant metabolism dysfunction, pulmonary |
| RS1489149705 |
NR2E3
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinal dystrophy, Enhanced S-cone syndrome |
| RS148915045 |
MYH6
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypertrophic cardiomyopathy 14, Cardiovascular phenotype |
| RS148915942 |
DGUOK
|
Health Risk |
Conflicting classifications of pathogenicity |
Mitochondrial DNA depletion syndrome 3 (hepatocerebral type), Mitochondrial DNA depletion syndrome 3 (hepatocerebral type) |
| RS1489165107 |
DNAH11
|
Health Risk |
Pathogenic/Likely pathogenic |
Primary ciliary dyskinesia, DNAH11-related disorder |
| RS148916790 |
LZTR1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Cardiovascular phenotype |
| RS1489175048 |
CEP290
|
Health Risk |
Pathogenic |
Nephronophthisis, Meckel-Gruber syndrome |
| RS1489175329 |
TSC1
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 1, Lymphangiomyomatosis |
| RS1489175898 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS148917889 |
ELP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial dysautonomia, Familial dysautonomia |
| RS148917929 |
AMT
|
Health Risk |
Conflicting classifications of pathogenicity |
Glycine encephalopathy, Glycine encephalopathy |
| RS1489180181 |
AXIN2
|
Health Risk |
Conflicting classifications of pathogenicity |
Oligodontia-cancer predisposition syndrome, Hereditary cancer-predisposing syndrome |
| RS148918111 |
RP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS148918486 |
COL3A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Ehlers-Danlos syndrome, type 4 |
| RS148918729 |
GNPTAB
|
Health Risk |
Conflicting classifications of pathogenicity |
Mucolipidosis type II, Pseudo-Hurler polydystrophy |
| RS148918985 |
ASS1
|
Health Risk |
Pathogenic/Likely pathogenic |
Citrullinemia, Citrullinemia type I |
| RS1489209061 |
NR0B1
|
Health Risk |
Pathogenic |
Congenital adrenal hypoplasia, X-linked |
| RS148920986 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiomyopathy, Congenital multicore myopathy with external ophthalmoplegia |
| RS1489216585 |
ACY1
|
Health Risk |
Pathogenic |
— |
| RS148921681 |
CASS4
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1489217206 |
MUTYH
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial adenomatous polyposis 2, Hereditary cancer-predisposing syndrome |
| RS148921993 |
YARS2
|
Health Risk |
Conflicting classifications of pathogenicity |
YARS2-related disorder, YARS2-related disorder |
| RS1489220084 |
PNPLA8
|
Health Risk |
Pathogenic |
— |
| RS1489224386 |
BLM
|
Health Risk |
Likely pathogenic |
Bloom syndrome, Bloom syndrome |
| RS148923187 |
BRAT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neonatal-onset encephalopathy with rigidity and seizures, Inborn genetic diseases |
| RS1489240592 |
COL2A1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1489245076 |
POLE
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS148924904 |
TP53
|
Health Risk |
Pathogenic |
Li-Fraumeni syndrome, Hereditary cancer-predisposing syndrome |
| RS148925399 |
DYSF
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin, Autosomal recessive limb-girdle muscular dystrophy type 2B |
| RS148925426 |
ATP2A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Brody myopathy, ATP2A1-related disorder |
| RS148925505 |
SACS
|
Health Risk |
Conflicting classifications of pathogenicity |
Charlevoix-Saguenay spastic ataxia, Spastic paraplegia |
| RS148925665 |
LAMC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Junctional epidermolysis bullosa, LAMC2-related disorder |
| RS1489258620 |
BPTF
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS148925938 |
PIGN
|
Health Risk |
Pathogenic |
Multiple congenital anomalies-hypotonia-seizures syndrome 1, Multiple congenital anomalies-hypotonia-seizures syndrome 1 |
| RS1489262806 |
IL36RN
|
Health Risk |
Likely pathogenic |
Generalized pustular psoriasis, Generalized pustular psoriasis |
| RS148927296 |
MCM4
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary immunodeficiency with natural-killer cell deficiency and adrenal insufficiency, MCM4-related disorder |
| RS148927511 |
SIL1
|
Health Risk |
Conflicting classifications of pathogenicity |
Marinesco-Sjögren syndrome, Marinesco-Sjögren syndrome |
| RS148927894 |
CIZ1
|
Health Risk |
Conflicting classifications of pathogenicity |
Dystonic disorder, Dystonic disorder |
| RS148928178 |
PAX1
|
Health Risk |
Conflicting classifications of pathogenicity |
PAX1-related disorder, PAX1-related disorder |
| RS148928808 |
STK11
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Peutz-Jeghers syndrome |
| RS148929548 |
COL4A6
|
Health Risk |
Conflicting classifications of pathogenicity |
Hearing loss, X-linked 6 |
| RS1489297664 |
BCL11A
|
Health Risk |
Likely pathogenic |
Dias-Logan syndrome, Dias-Logan syndrome |
| RS148930043 |
DOLK
|
Health Risk |
Conflicting classifications of pathogenicity |
DK1-congenital disorder of glycosylation, Cardiovascular phenotype |
| RS1489308019 |
PSAP
|
Health Risk |
Pathogenic |
Sphingolipid activator protein 1 deficiency, Sphingolipid activator protein 1 deficiency |
| RS148930837 |
SCO2
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1489314131 |
ATP13A3
|
Health Risk |
Likely pathogenic |
Pulmonary arterial hypertension, Pulmonary hypertension |
| RS148931484 |
SALL1
|
Health Risk |
Conflicting classifications of pathogenicity |
Townes syndrome, SALL1-related disorder |
| RS1489315815 |
CAVIN1
|
Health Risk |
Pathogenic |
Congenital generalized lipodystrophy type 4, Congenital generalized lipodystrophy type 4 |
| RS148931779 |
TSC1
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 1, Hereditary cancer-predisposing syndrome |
| RS148931962 |
IL7R
|
Health Risk |
Conflicting classifications of pathogenicity |
Immunodeficiency 104, Immunodeficiency 104 |
| RS148932047 |
POLR3A
|
Health Risk |
Pathogenic |
Neonatal pseudo-hydrocephalic progeroid syndrome, Leukodystrophy |
| RS148932323 |
PKHD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive polycystic kidney disease, Polycystic kidney disease |
| RS148932488 |
NOTCH3
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS148933850 |
ALG1
|
Health Risk |
Conflicting classifications of pathogenicity |
ALG1-congenital disorder of glycosylation, Inborn genetic diseases |
| RS1489341724 |
CCDC40
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS148934350 |
EGFR
|
Health Risk |
Conflicting classifications of pathogenicity |
Lung carcinoma, EGFR-related lung cancer |
| RS1489345430 |
PALB2
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS148934699 |
KIF1C
|
Health Risk |
Conflicting classifications of pathogenicity |
Spastic ataxia 2, Hereditary spastic paraplegia |
| RS1489351299 |
COL4A4
|
Health Risk |
Pathogenic |
Autosomal recessive Alport syndrome, Inborn genetic diseases |
| RS148935165 |
DCHS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS148935214 |
RET
|
Health Risk |
Conflicting classifications of pathogenicity |
Elevated basal serum calcitonin, Hereditary cancer-predisposing syndrome |
| RS1489355776 |
BRIP1
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS148935596 |
SYNE1
|
Health Risk |
Conflicting classifications of pathogenicity |
Emery-Dreifuss muscular dystrophy 4, autosomal dominant |
| RS148935720 |
MPDU1
|
Health Risk |
Conflicting classifications of pathogenicity |
MPDU1-congenital disorder of glycosylation, MPDU1-congenital disorder of glycosylation |
| RS148936043 |
LMNB2
|
Health Risk |
Conflicting classifications of pathogenicity |
Lipodystrophy, partial |
| RS1489361512 |
ROR2
|
Health Risk |
Likely pathogenic |
Autosomal recessive Robinow syndrome, Autosomal recessive Robinow syndrome |
| RS148936510 |
MYPN
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1KK, Cardiovascular phenotype |
| RS148936584 |
DNAAF2
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS1489368528 |
KIF12
|
Health Risk |
Likely pathogenic |
Cholestasis, progressive familial intrahepatic |
| RS148936893 |
ADA2
|
Health Risk |
Pathogenic/Likely pathogenic |
Deficiency of adenosine deaminase 2, Sneddon syndrome |
| RS148937466 |
TP63
|
Health Risk |
Conflicting classifications of pathogenicity |
TP63-Related Spectrum Disorders, TP63-Related Spectrum Disorders |
| RS148937517 |
FKTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1X, Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies) |
| RS1489377964 |
DNAAF1
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS148938083 |
PDE6A
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa, Retinitis pigmentosa 43 |
| RS1489386089 |
XPA
|
Health Risk |
Pathogenic/Likely pathogenic |
Xeroderma pigmentosum group A, Xeroderma pigmentosum group A |
| RS1489387064 |
PNPLA2
|
Health Risk |
Pathogenic |
Neutral lipid storage myopathy, Neutral lipid storage myopathy |
| RS148938946 |
MYH11
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Aortic aneurysm |
| RS148939095 |
CASP10
|
Health Risk |
Conflicting classifications of pathogenicity |
Autoimmune lymphoproliferative syndrome type 2A, Autoimmune lymphoproliferative syndrome type 2A |
| RS148939701 |
CHRND
|
Health Risk |
Conflicting classifications of pathogenicity |
Lethal multiple pterygium syndrome, Congenital myasthenic syndrome |
| RS148939995 |
PRX
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease type 4, Charcot-Marie-Tooth disease |
| RS148940145 |
WDR87
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1489407796 |
LAMA3
|
Health Risk |
Likely pathogenic |
Epidermolysis bullosa, junctional 2B |
| RS148941150 |
POLG2
|
Health Risk |
Conflicting classifications of pathogenicity |
Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 4 |
| RS148941732 |
PRPF31
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS148942046 |
ANK1
|
Health Risk |
Conflicting classifications of pathogenicity |
Spherocytosis, Hereditary spherocytosis type 1 |
| RS148942084 |
MYPN
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1KK, Cardiovascular phenotype |
| RS148942346 |
GATA2
|
Health Risk |
Pathogenic |
Deafness-lymphedema-leukemia syndrome, GATA2 deficiency with susceptibility to MDS/AML |
| RS148942437 |
FBP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Fructose-biphosphatase deficiency, Fructose-biphosphatase deficiency |
| RS148942765 |
RPS26
|
Health Risk |
Pathogenic |
Diamond-Blackfan anemia 10, Diamond-Blackfan anemia 15 with mandibulofacial dysostosis |
| RS1489429320 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 2, Hereditary cancer-predisposing syndrome |
| RS148943299 |
APOB
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypercholesterolemia, autosomal dominant |
| RS148943954 |
ACE
|
Health Risk |
Conflicting classifications of pathogenicity |
Renal tubular dysgenesis, Renal tubular dysgenesis |
| RS1489439743 |
CCDC39
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |